Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zhongfan Ruan, Yan Li, Rongzhang He & Xuewei Li. (2021) Inhibition of microRNA-10b-5p up-regulates HOXD10 to attenuate Alzheimer’s disease in rats via the Rho/ROCK signalling pathway. Journal of Drug Targeting 29:5, pages 531-540.
Read now
Read now
Articles from other publishers (23)
Muhammad Imran Sajid, Fahad Sultan Sheikh, Faiza Anis, Nourina Nasim, Rachita K. Sumbria, Surya M. Nauli & Rakesh Kumar Tiwari. (2023) siRNA drug delivery across the blood–brain barrier in Alzheimer's disease. Advanced Drug Delivery Reviews 199, pages 114968.
Crossref
Crossref
Dhanshree Jha, Erik N. T. P. Bakker & Rahul Kumar. (2023)
Mechanistic and therapeutic role of
NLRP3
inflammasome in the pathogenesis of Alzheimer's disease
. Journal of Neurochemistry.
Crossref
Crossref
Shalini Mani, Divya Jindal, Hitesh Chopra, Saurabh Kumar Jha, Sachin Kumar Singh, Gulam Md Ashraf, Mehnaz Kamal, Danish Iqbal, Dinesh Kumar Chellappan, Abhijit Dey, Saikat Dewanjee, Keshav K. Singh, Shreesh Ojha, Inderbir Singh, Rupesh K. Gautam & Niraj Kumar Jha. (2022) ROCK2 inhibition: A futuristic approach for the management of Alzheimer’s disease. Neuroscience & Biobehavioral Reviews 142, pages 104871.
Crossref
Crossref
Philippe Delbreil, Jean-Michel Rabanel, Xavier Banquy & Davide Brambilla. (2022) Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings. Advanced Drug Delivery Reviews 187, pages 114397.
Crossref
Crossref
Yunyun Liu, Han Zhang, Anping Peng, Xiaodong Cai, YuZhou Wang, Ke Tang, Xiuqin Wu, Yanran Liang, Limin Wang & Zhong Li. (2021) PEG-PEI/siROCK2 inhibits Aβ42-induced microglial inflammation via NLRP3/caspase 1 pathway. NeuroReport 33:1, pages 26-32.
Crossref
Crossref
Sanjay Arora, Divya Sharma, Buddhadev Layek & Jagdish Singh. (2021) A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer’s Disease. Molecular Pharmaceutics 18:12, pages 4237-4255.
Crossref
Crossref
Desyrre V. Tedeschi, Anderson F da Cunha, Márcia R. Cominetti & Renata Valle Pedroso. (2021) Efficacy of Gene Therapy to Restore Cognition in Alzheimer’s Disease: A Systematic Review. Current Gene Therapy 21:3, pages 246-257.
Crossref
Crossref
Benoit Schneider, Anne Baudry, Mathéa Pietri, Aurélie Alleaume-Butaux, Chloé Bizingre, Pierre Nioche, Odile Kellermann & Jean-Marie Launay. (2021) The Cellular Prion Protein—ROCK Connection: Contribution to Neuronal Homeostasis and Neurodegenerative Diseases. Frontiers in Cellular Neuroscience 15.
Crossref
Crossref
Hossein Derakhshankhah, Soraya Sajadimajd, Samira Jafari, Zhila Izadi, Sajad Sarvari, Majid Sharifi, Mojtaba Falahati, Faezeh Moakedi, Willis Collins Akeyo Muganda, Mareike Müller, Mohammad Raoufi & John F. Presley. (2020) Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 24, pages 102149.
Crossref
Crossref
Ye Gao, Yuqing Yan, Qingli Fang, Nianping Zhang, Gajendra Kumar, Jihong Zhang, Li-Juan Song, Jiezhong Yu, Linhu Zhao, Han-Ting Zhang & Cun-Gen Ma. (2019) The Rho kinase inhibitor fasudil attenuates Aβ1–42-induced apoptosis via the ASK1/JNK signal pathway in primary cultures of hippocampal neurons. Metabolic Brain Disease 34:6, pages 1787-1801.
Crossref
Crossref
Kevin Liaw, Zhi Zhang & Sujatha Kannan. (2019) Neuronanotechnology for brain regeneration. Advanced Drug Delivery Reviews 148, pages 3-18.
Crossref
Crossref
Jinpeng Pan, Yan Yin, Lianhua Zhao & Yangbo Feng. (2019) Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors. Bioorganic & Medicinal Chemistry 27:7, pages 1382-1390.
Crossref
Crossref
Xiaojie Song, Rong He, Wei Han, Tianyi Li, Lingling Xie, Li Cheng, Hengsheng Chen, Mingdan Xie & Li Jiang. (2018) Protective effects of the ROCK inhibitor fasudil against cognitive dysfunction following status epilepticus in male rats. Journal of Neuroscience Research 97:4, pages 506-519.
Crossref
Crossref
YanaO Mukhamedshina, OlgaA Gracheva, DinaM Mukhutdinova, YuriiA Chelyshev & AlbertA Rizvanov. (2019) Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury. Neural Regeneration Research 14:2, pages 227.
Crossref
Crossref
Jan Christoph Koch, Lars Tatenhorst, Anna-Elisa Roser, Kim-Ann Saal, Lars Tönges & Paul Lingor. (2018) ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacology & Therapeutics 189, pages 1-21.
Crossref
Crossref
Jiezhong Yu, Yuqing Yan, Qingfang Gu, Gajendra Kumar, Hongqiang Yu, Yijin Zhao, Chunyun Liu, Ye Gao, Zhi Chai, Jasleen Chumber, Bao-Guo Xiao, Guang-Xian Zhang, Han-Ting Zhang, Yuqiang Jiang & Cun-Gen Ma. (2018) Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer’s Disease-Related Changes Through the Regulation of the Peripheral Immune System. Frontiers in Aging Neuroscience 10.
Crossref
Crossref
Aaron Y. Lai & JoAnne McLaurin. (2018) Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease. Journal of Neurochemistry 144:5, pages 659-668.
Crossref
Crossref
M.C. Teixeira, C. Martins-Gomes, K.K. Singh, F.J. Veiga, A.M. Silva & E.B. Souto. 2018. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors
147
168
.
Chuipu Cai, Qihui Wu, Yunxia Luo, Huili Ma, Jiangang Shen, Yongbin Zhang, Lei Yang, Yunbo Chen, Zehuai Wen & Qi Wang. (2017) In silico prediction of ROCK II inhibitors by different classification approaches. Molecular Diversity 21:4, pages 791-807.
Crossref
Crossref
K.H. Reeta, Devendra Singh & Y.K. Gupta. (2017) Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. Neurochemistry International 108, pages 146-156.
Crossref
Crossref
K. H. Reeta, Devendra Singh & Yogendra K. Gupta. (2017) Edaravone attenuates intracerebroventricular streptozotocin-induced cognitive impairment in rats. European Journal of Neuroscience 45:7, pages 987-997.
Crossref
Crossref
Yunyun Liu, Xingyi Yang, Qingfeng Lei, Zhong Li, Jingyang Hu, Xiaojun Wen, Huijun Wang & Zhonglin Liu. (2015) PEG–PEI/siROCK2 Protects Against Aβ42-Induced Neurotoxicity in Primary Neuron Cells for Alzheimer Disease. Cellular and Molecular Neurobiology 35:6, pages 841-848.
Crossref
Crossref
Fan Xu, Hui Huang, Yu Wu, Lu Lu, Li Jiang, Lifei Chen, Siming Zeng, Li Li & Min Li. (2014) Upregulation of Gem relates to retinal ganglion cells apoptosis after optic nerve crush in adult rats. Journal of Molecular Histology 45:5, pages 565-571.
Crossref
Crossref